Wells Fargo Raises Merck (MRK) Target on Sac-TMT Potential
On March 12, Wells Fargo raised its price recommendation on Merck & Co., Inc. (NYSE:MRK) to $150 from $135. It maintained an Overweight rating on the shares.
Merck Sharp & Dohme Corp. (MRK)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (MRK) is currently associated with the following stock: Merck & Co. Inc. (MRK)
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | $18,268.75 | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | $9,130.56 | 200 | 2002-09-24 | Filing |
News See All
15 Best Safe Dividend Stocks for 2026
Dividends are drawing more attention from investors this year.
Here’s Why Merck (MRK) Surged in Q4
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Value Fund”. A copy of the letter can be downloaded here.
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now?
Is MRK a good stock to buy now? We came across a bullish thesis on Merck & Co., Inc. on Investomine’s Substack. In this article, we will summarize the bulls’ thesis on MRK.
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss
Merck & Co., Inc. (NYSE:MRK) is one of Goldman Sachs top healthcare stocks. On March 3 at the TD Cowen 46th Annual Health Care Conference, Merck & Co., Inc.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Leerink Raises Merck & Co. Inc. (MRK) Price Target, Sees Upside from Cancer Drug
Merck & Co. Inc. (NYSE:MRK) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On March 2, Leerink Partners boosted its price target for Merck & Co. Inc.
Starter Stock Portfolio: 14 Safe Stocks to Buy Now
Global stock markets have continued to struggle as oil prices surged to their highest weekly spike in six years, with no signs of an imminent end to the Middle East conflict.
RBC Capital Sees Merck (MRK) Returning to Growth Sooner Than Market Expects
On February 25, RBC Capital initiated coverage of Merck & Co., Inc. (NYSE:MRK) with an Outperform rating and a $142 price target.
14 Best Affordable Dividend Stocks to Buy According to Analysts
According to a report from Franklin Templeton, dividends have played a much larger role in investor returns than many people realize.
Hedge Fund Resource Center